AEZS

AEterna Zentaris Inc. News Headlines

$1.1
*  
0.01
0.9%
Get AEZS Alerts
*Delayed - data as of Oct. 30, 2014 13:12 ET  -  Find a broker to begin trading AEZS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AEZS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
AEterna Zentaris: The Bear Case In Front Of The November 5th PDUFA
10/30/2014 9:24:00 AM - Seeking Alpha


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


AEterna Zentaris Has A Great Value Proposition - CEO David Dodd Explains Why
9/23/2014 10:19:00 AM - Seeking Alpha


Aeterna Zentaris: A Risk Worth Taking
9/9/2014 1:54:00 PM - Seeking Alpha


Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha


Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha


Update on Coronado's TSO - Analyst Blog
12/16/2013 5:33:06 PM - Zacks.com


Endocyte Enrolls First Patient in Study - Analyst Blog
12/13/2013 7:27:01 PM - Zacks.com


SUPN Presents Data on Drugs at AES - Analyst Blog
12/13/2013 5:10:01 PM - Zacks.com


Aeterna Zentaris: Mispriced $1 Biotech Stock With Limited Downside Risk And Big Upside Potential
12/12/2013 1:15:00 PM - Seeking Alpha


ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog
12/9/2013 5:05:58 PM - Zacks.com


Update on KaloBios' KB004 - Analyst Blog
12/6/2013 7:06:12 PM - Zacks.com


Update on Pacira's Exparel - Analyst Blog
12/6/2013 7:04:54 PM - Zacks.com


NDA for AcelRx's Zalviso Accepted - Analyst Blog
12/5/2013 8:04:01 PM - Zacks.com


JAZZ Briefs at Healthcare Conference - Analyst Blog
12/5/2013 6:05:52 PM - Zacks.com


Final Guidance from NICE for pSivida's Iluvien - Analyst Blog
12/5/2013 6:00:01 PM - Zacks.com


Setback for Lexicon Pharma - Analyst Blog
12/5/2013 5:05:10 PM - Zacks.com


Data on NVO's Diabetes Drugs - Analyst Blog
12/4/2013 5:04:51 PM - Zacks.com


Sangamo Biosciences (SGMO) in Focus: Stock Rises 5.8% - Tale of the Tape
12/4/2013 9:53:58 AM - Zacks.com


Biogen's Hemophilia B Drug Approval Delayed - Analyst Blog
12/3/2013 5:50:01 PM - Zacks.com


Actelion's Update on Opsumit - Analyst Blog
12/3/2013 5:45:01 PM - Zacks.com


Aeterna Zentaris Closes Public Offering - Analyst Blog
12/2/2013 5:53:39 PM - Zacks.com


New Data on Aegerion's Juxtapid - Analyst Blog
11/19/2013 8:06:33 PM - Zacks.com


U.S. Launch of Actelion's Valchlor - Analyst Blog
11/19/2013 5:45:01 PM - Zacks.com


Zacks #5 Rank Additions for Tuesday - Tale of the Tape
11/19/2013 10:07:15 AM - Zacks.com